美国县级肝病死亡率差异:社会人口学、疾病风险因素和就医可及性的影响
该研究利用美国CDC 2009-2018年县级数据,分析肝病相关死亡率(肝硬化+肝细胞癌)的县级差异。多变量模型显示,61%的县际死亡率变异可由种族/民族、贫困、无保险率、距移植中心距离及肥胖、糖尿病、酒精使用率解释。调整后仍存在显著州内差异,死亡率最高5%的县中60%位于俄克拉荷马、德克萨斯和新墨西哥三州。
要点
- 县级肝病死亡率变异61%可由人口学、临床风险因素和就医可及性解释。
- 调整后州内差异仍显著,高死亡率县聚集于特定区域。
- 最高死亡率5%的县中60%位于OK、TX、NM三州。
核心结论
- 肝病相关死亡率存在显著州内县级差异,超过60%的变异由患者人口学、肝病临床风险因素和专科肝病就医可及性解释。
研究设计与样本
- 基于美国CDC WONDER数据库2009-2018年数据,计算县年龄调整肝病相关死亡率,拟合多变量线性回归模型调整人口学、合并症、就医可及性和地理变量,并使用优化热点分析识别死亡率热点聚类。
主要发现
- 多变量模型中,61%的县际死亡率变异由县级种族/民族、贫困、无保险率、距最近移植中心距离以及肥胖、糖尿病和酒精使用率解释。
- 调整后仍发现显著的州内县级死亡率变异。
- 完全调整后死亡率最高第五百分位的县中,60%位于俄克拉荷马、德克萨斯和新墨西哥三州。
- 调整后死亡率呈高度空间相关性,形成5个聚类:南佛罗里达;阿巴拉契亚和中西部东部;德克萨斯和俄克拉荷马;新墨西哥、亚利桑那、加利福尼亚和俄勒冈南部;华盛顿和蒙大拿部分地区。
临床怎么用
- 临床医生应关注肝病死亡率的本地化差异,尤其在识别出的热点区域加强肝病筛查和专科转诊。
- 政策制定者可针对贫困、无保险和专科就医可及性等可干预因素制定区域性干预策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Data have demonstrated state-wide variability in mortality rates from liver disease (cirrhosis + hepatocellular carcinoma), but data are lacking at the local level (eg, county) to identify factors associated with variability in liver disease-related mortality and hotspots of liver disease mortality. METHODS: We used Centers for Disease Control and Prevention's Wide-ranging Online Data for Epidemiologic Research data from 2009 to 2018 to calculate county-level, age-adjusted liver disease-related death rates. We fit multivariable linear regression models to adjust for county-level covariates related to demographics (ie, race and ethnicity), medical comorbidities (eg, obesity), access to care (eg, uninsured rate), and geographic (eg, distance to closest liver transplant center) variables. We used optimized hotspot analysis to identify clusters of liver disease mortality hotspots based on the final multivariable models. RESULTS: In multivariable models, 61% of the variability in among-county mortality was explained by county-level race/ethnicity, poverty, uninsured rates, distance to the closest transplant center, and local rates of obesity, diabetes, and alcohol use. Despite adjustment, significant within-state variability in county-level mortality rates was found. Of counties in the top fifth percentile (ie, highest mortality) of fully adjusted mortality, 60% were located in 3 states: Oklahoma, Texas, and New Mexico. Adjusted mortality rates were highly spatially correlated, representing 5 clusters: South Florida; Appalachia and the eastern part of the Midwest; Texas and Oklahoma; New Mexico, Arizona, California, and southern Oregon; and parts of Washington and Montana. CONCLUSIONS: Our data demonstrate significant intrastate differences in liver disease-related mortality, with more than 60% of the variability explained by patient demographics, clinical risk factors for liver disease, and access to specialty liver care.
引用
- Goldberg D, Ross-Driscoll K, Lynch R, et al. County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care. Gastroenterology. 2020. PMID: 33220253. doi:10.1053/j.gastro.2020.11.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。